July 7 (Reuters) - Century Therapeutics Inc IPSC.O:
CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILING
CENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILING
CENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILING
CENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING
CENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025